N-cadherin regulates mammary tumor cell migration through Akt3 suppression

被引:43
作者
Chung, S. [1 ]
Yao, J. [1 ]
Suyama, K. [1 ]
Bajaj, S. [1 ]
Qian, X. [1 ]
Loudig, O. D. [1 ]
Eugenin, E. A. [1 ]
Phillips, G. R. [2 ]
Hazan, R. B. [1 ]
机构
[1] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[2] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA
关键词
adhesion; motility; Akt isoforms; Akt3; breast cancer; BREAST-CANCER; FGF-RECEPTOR; SIGNALING PATHWAY; METASTASIS; ACTIVATION; EXPRESSION; PROGRESSION; PROLIFERATION; ISOFORMS; PROTEIN;
D O I
10.1038/onc.2012.65
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-cadherin is a cell-cell adhesion molecule that plays a role in breast cancer metastasis. Here, we show that in vivo expression of N-cadherin in the PyMT mouse model, which enhances mammary tumor metastasis, results in selective inhibition of Akt3 expression and phosphorylation. Similarly, exogenous expression of N-cadherin in PyMT or MCF-7 mammary tumor cells enhanced cell motility and caused a dramatic reduction in Akt3 expression and phosphorylation. Moreover, knockdown of Akt3 in PyMT tumor cells increased cell motility and disrupted mammary morphogenesis, but had no effect on cell proliferation. Conversely, overexpression of wild-type Akt3 in PyMT-N-cadherin cells inhibited cell motility promoted by N-cadherin. Taken altogether, these findings demonstrate that N-cadherin suppresses Akt3 to promote cell motility and highlight the intricate regulation of Akt isoforms by N-cadherin during metastasis. Oncogene (2013) 32, 422-430; doi:10.1038/onc.2012.65; published online 12 March 2012
引用
收藏
页码:422 / 430
页数:9
相关论文
共 27 条
[1]   Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression [J].
Agiostratidou, Georgia ;
Hulit, James ;
Phillips, Greg R. ;
Hazan, Rachel B. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2007, 12 (2-3) :127-133
[2]   Loss of Retinal Cadherin Facilitates Mammary Tumor Progression and Metastasis [J].
Agiostratidou, Georgia ;
Li, Maomi ;
Suyama, Kimita ;
Badano, Ines ;
Keren, Rinat ;
Chung, Su ;
Anzovino, Amy ;
Hulit, James ;
Qian, Binzhi ;
Bouzahzah, Boumediene ;
Eugenin, Eliseo ;
Loudig, Olivier ;
Phillips, Greg R. ;
Locker, Joseph ;
Hazan, Rachel B. .
CANCER RESEARCH, 2009, 69 (12) :5030-5038
[3]   Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].
Bellacosa, A ;
Kumar, CC ;
Di Cristofano, A ;
Testa, JR .
ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+
[4]   PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms [J].
Brognard, John ;
Sierecki, Emma ;
Gao, Tianyan ;
Newton, Alexandra C. .
MOLECULAR CELL, 2007, 25 (06) :917-931
[5]  
Cavallaro Ugo, 2004, Curr Opin Investig Drugs, V5, P1274
[6]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[7]   The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration [J].
Chin, Y. Rebecca ;
Toker, Alex .
MOLECULAR CELL, 2010, 38 (03) :333-344
[8]   Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer [J].
Chin, Y. Rebecca ;
Toker, Alex .
CELLULAR SIGNALLING, 2009, 21 (04) :470-476
[9]   Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner [J].
Debnath, J ;
Walker, SJ ;
Brugge, JS .
JOURNAL OF CELL BIOLOGY, 2003, 163 (02) :315-326
[10]   Distinct Biological Roles for the Akt Family in Mammary Tumor Progression [J].
Dillon, Rachelle L. ;
Muller, William J. .
CANCER RESEARCH, 2010, 70 (11) :4260-4264